StockrabitBrowse analysts
Analyst questions

Amlan Jyoti Das

JPMorgan
ALKEM

Alkem Laboratories Limited

All company calls
FY2027 Q1
14 Aug 2026
Open call
  1. Sir, my question is regarding the India biosimilar...

    Read in transcript
  2. Yes. Is it alright now?

    Read in transcript
  3. Yes. My question is regarding the India biosimilar front. You had some 6 to 7 -odd biosimilars in India launched for the India entity. How has this portfolio done over the -- since launch? And what has been contribution to the India revenues per se?

    Read in transcript
+7 more questions in this call